Medibank Private
- Short interest
- 3.68%
- +0.62 pp 30d
- as of 8 Oct 2026
- Reported shorts
- 101.5M
- Shares on issue
- 2.754B
Medibank Private (MPL) Short Interest
Medibank Private (ASX:MPL) had 3.68% of shares reported as short positions as of 8 Oct 2026, representing 101,479,200 shares. Medibank Private operates in the Insurance industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Medibank Private
Medibank Private (ASX: MPL) is an Australian health company whose core business is underwriting and distributing private health insurance, complemented by health services and adjacent insurance offerings (including pet and travel insurance). It is one of Australia’s largest private health insurers, with scale in policyholder membership, brand recognition, and a broad distribution footprint across direct and partner channels. The group’s value proposition centres on integrated health management, preventative health programs and digital servicing aimed at improving member outcomes while managing claims costs.
Company profile →Medibank Private (ASX:MPL) has 3.68% of its shares on issue reported as short positions as of 8 Oct 2026, or about 101,479,200 shares. Over the past 30 days that figure has risen 0.62 percentage points, and over 90 days it has risen 0.37 percentage points. Its highest recorded short interest was 3.93% in June 2026. MPL is classified in the Insurance industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads MPL today
- Zanger BreakoutWatchScore 42rank 177 of 1942
- CAN SLIMWatchScore 25rank 403 of 1541
- Minervini Trend TemplateWatchScore 22rank 763 of 1716
- Crowded-Short BreakoutWatchScore 25rank 177 of 1502
- Quality compoundersWatchScore 34rank 336 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
MPL fundamentals
In the year to 30 Jun 2026, Medibank Private (ASX:MPL) recorded revenue of A$9.3B and net profit after tax of A$638.7M. A year earlier it recorded revenue of A$8.5B and net profit after tax of A$500.8M. Year-on-year growth: revenue +9.3% (FY), EPS +27.5% (FY). Net margin 6.8%, return on equity 26.8% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest MPL news
All news- Medibank Private And 2 Other Australian Dividend Stocks - Simply Wall Street
googlenews · 14 Oct 2026
- Can Medibank Private (ASX:MPL) Lead Australia's Dividend Pack? - Kalkine Media
googlenews · 11 Oct 2026
- Proxy Form 2026
asx · 8 Oct 2026
Company details
More Insurance Stocks
Other shorted stocks in this sector
Be the first to discuss MPL
Start a research thread or post the first pulse update